Drugs / 2007-2008 Influenza Virus Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00561002 | Oct 2007 → May 2008 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2007-2008 Influenza Virus Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00561002 ↗ |
| Modality | Vaccine | “2007-2008 formulation of the inactivated, split-virion influenza vaccine Fluzone®” NCT00561002 ↗ |
| Route | Intramuscular | “0.25 mL, Intramuscular” NCT00561002 ↗ |